Publication | Open Access
<p>Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects</p>
43
Citations
41
References
2019
Year
Aprocitentan was well tolerated in healthy subjects with a PK profile favorable for qd dosing.
| Year | Citations | |
|---|---|---|
Page 1
Page 1